UBS Group AG - SPRING BK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$3,000
+200.0%
2,242
+348.4%
0.00%
Q2 2020$1,000
-75.0%
500
-89.6%
0.00%
Q1 2020$4,000
+300.0%
4,792
+858.4%
0.00%
Q4 2019$1,000
-87.5%
500
-78.8%
0.00%
Q3 2019$8,000
-52.9%
2,358
-50.3%
0.00%
Q2 2019$17,000
-37.0%
4,743
+85.7%
0.00%
Q1 2019$27,000
-67.9%
2,554
-68.3%
0.00%
Q4 2018$84,000
+2.4%
8,065
+18.6%
0.00%
Q3 2018$82,000
+141.2%
6,802
+135.0%
0.00%
Q2 2018$34,000
+3.0%
2,894
+38.1%
0.00%
Q1 2018$33,000
+50.0%
2,096
+31.0%
0.00%
Q4 2017$22,000
-35.3%
1,600
-20.0%
0.00%
Q3 2017$34,0000.0%2,000
-20.3%
0.00%
Q2 2017$34,000
+61.9%
2,510
+7.8%
0.00%
Q1 2017$21,000
+425.0%
2,328
+517.5%
0.00%
Q2 2016$4,0003770.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 951,701$9,983,0001.12%
Morse Asset Management, Inc 149,175$1,565,0000.47%
SECTORAL ASSET MANAGEMENT INC 276,656$2,902,0000.35%
PARSONS CAPITAL MANAGEMENT INC/RI 276,963$2,905,0000.32%
CAXTON CORP 23,717$249,0000.23%
TIEDEMANN ADVISORS, LLC 412,049$4,323,0000.20%
Private Capital Advisors, Inc. 52,335$549,0000.17%
Pegasus Asset Management, Inc. 18,750$197,0000.16%
Hikari Power Ltd 53,536$562,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 51,015$535,0000.05%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders